THE TWENTY-NINTH LEGISLATURE
REGULAR SESSION OF 2017
Senator Rosalyn H. Baker, Chair |
Senator Clarence K. Nishihara, Vice Chair |
COMMITTEE ON PUBLIC SAFETY, INTERGOVERNMENTAL, AND MILITARY AFFAIRS |
Senator Clarence K. Nishihara, Chair |
Senator Glenn Wakai, Vice Chair |
AMENDED NOTICE OF HEARING
DATE: |
Thursday, February 9, 2017 |
TIME: |
1:15pm |
PLACE: |
Conference Room 229 State Capitol 415 South Beretania Street |
A M E N D E D A G E N D A
RELATING TO MEDICAL COVERAGE FOR FIREFIGHTERS. Improves access for firefighters to comprehensive medical coverage and service-connected disability retirement benefits for hazardous duty related diseases that are presumed to arise out of and in the course of employment.
|
CPH/PSM, JDL/WAM |
|
RELATING TO THE CONTROLLED SUBSTANCES ACT. Amends Hawaii's controlled substances act to mirror federal regulations, which permit qualified practitioners to administer, dispense, and prescribe any schedule III, IV, or V narcotic drug approved by the Food and Drug Administration for use as a detoxification treatment or maintenance treatment; provided the practitioner complies with specific federal requirements.
|
CPH/PSM, JDL |
|
RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. Updates chapter 329, Hawaii Revised Statutes as follows: amends sections 329-16 and 329-38(f) to be consistent with federal law which allows prescribing authorization of drugs including buprenorphine and naloxone to patients undergoing detoxification treatment and maintenance treatment by practitioners who are properly registered. Requires that the collections of fines under section 329-49 be deposited into the State controlled substance registration revolving fund under section 329-59 to support the program.
|
CPH/PSM, WAM
[Measure added on 2/2/2017] |
|
RELATING TO NATUROPATHIC MEDICINE. Authorizes a naturopathic physician to prescribe controlled substances that are consistent with naturopathic medical practice. Clarifies that narcotic drugs shall not be included within the naturopathic formulary.
|
CPH/PSM, JDL/WAM |
|
RELATING TO MEDICAL MARIJUANA. Clarifies that an adequate supply of medical marijuana authorized for possession by a qualifying patient and the primary caregiver includes seven marijuana plants that are at least twelve inches in height or width, and seven marijuana seedlings that are less than twelve inches in height and width. Authorizes primary caregivers to continue cultivating marijuana for qualifying patients after December 31, 2018. Allows a felon to work in the medical marijuana industry if the individual has not served time in prison for a felony conviction in the five years immediately preceding the employment. Defines edible cannabis products as manufactured cannabis that is intended to be used, in whole or in part, for human consumption. Authorizes licensed medical marijuana dispensaries to manufacture and distribute edible cannabis products beginning July 1, 2018.
|
CPH/PSM, JDL/WAM
[Measure added on 2/2/2017] |
|
|
|
|
Decision Making to follow, if time permits.
Click here to submit testimony to the Senate Committee on Commerce, Consumer Protection, and Health.
Testimony may be submitted up to 24 hours prior to the start of the hearing.
FOR AMENDED NOTICES: Measures that have been deleted are stricken through and measures that have been added are underscored. If a measure is both underscored and stricken through, that measure has been deleted from the agenda.
If you require auxiliary aids or services to participate in the public hearing process (i.e. ASL or foreign language interpreter, or wheelchair accessibility), please contact the committee clerk at least 24 hours prior to the hearing so that arrangements can be made.
FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808)586-6070.
_____________________________________ Senator Clarence K. Nishihara Chair |
|
_____________________________________ Senator Rosalyn H. Baker Chair |
|
|
|